ID29250A - Stabilisasi makrolida - Google Patents

Stabilisasi makrolida

Info

Publication number
ID29250A
ID29250A IDW00200101156A ID20011156A ID29250A ID 29250 A ID29250 A ID 29250A ID W00200101156 A IDW00200101156 A ID W00200101156A ID 20011156 A ID20011156 A ID 20011156A ID 29250 A ID29250 A ID 29250A
Authority
ID
Indonesia
Prior art keywords
macrolida
stabilization
macrolida stabilization
Prior art date
Application number
IDW00200101156A
Other languages
English (en)
Indonesian (id)
Inventor
Francois Navarro
Samuel Petit
Guy Stone
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26314797&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ID29250(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of ID29250A publication Critical patent/ID29250A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/18—Bridged systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
IDW00200101156A 1998-12-07 1999-12-06 Stabilisasi makrolida ID29250A (id)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9826882.4A GB9826882D0 (en) 1998-12-07 1998-12-07 Organic compounds
GBGB9904934.8A GB9904934D0 (en) 1998-12-07 1999-03-04 Organic compounds

Publications (1)

Publication Number Publication Date
ID29250A true ID29250A (id) 2001-08-16

Family

ID=26314797

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW00200101156A ID29250A (id) 1998-12-07 1999-12-06 Stabilisasi makrolida

Country Status (38)

Country Link
US (5) US6605613B2 (de)
EP (4) EP1743657A3 (de)
JP (3) JP3805625B2 (de)
KR (2) KR20060096477A (de)
CN (2) CN1261163C (de)
AR (3) AR026102A1 (de)
AT (1) ATE365051T1 (de)
AU (1) AU759219B2 (de)
BE (1) BE1012869A3 (de)
BR (1) BR9915986A (de)
CA (3) CA2732620C (de)
CO (1) CO4980847A1 (de)
CY (1) CY1106870T1 (de)
CZ (2) CZ303006B6 (de)
DE (1) DE69936352T3 (de)
DK (1) DK1137439T4 (de)
ES (1) ES2288033T5 (de)
FR (1) FR2786771B1 (de)
GB (2) GB9826882D0 (de)
HK (1) HK1038889B (de)
HU (2) HU228939B1 (de)
ID (1) ID29250A (de)
IL (1) IL143092A0 (de)
IT (1) IT1319701B1 (de)
MY (2) MY120594A (de)
NO (2) NO332698B1 (de)
NZ (2) NZ511936A (de)
PE (1) PE20001333A1 (de)
PL (2) PL208854B1 (de)
PT (1) PT1137439E (de)
RU (1) RU2243769C2 (de)
SG (1) SG151072A1 (de)
SI (1) SI1137439T2 (de)
SK (2) SK287325B6 (de)
TR (2) TR200201428T2 (de)
TW (2) TWI248938B (de)
WO (1) WO2000033878A2 (de)
ZA (1) ZA200104360B (de)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070032853A1 (en) 2002-03-27 2007-02-08 Hossainy Syed F 40-O-(2-hydroxy)ethyl-rapamycin coated stent
US7452692B2 (en) 2002-02-13 2008-11-18 Teva Gyógyszergyár Zártkörüen Müködö Részvénytársaság Method for extracting a macrolide from biomatter
MXPA04007847A (es) 2002-02-13 2005-02-24 Biogal Gyogyszergyar Metodo para extraer un macrolido de biomateria.
RU2344821C2 (ru) 2002-07-30 2009-01-27 Уайт Парентеральные композиции, содержащие гидроксиэфиры рапамицина
WO2004089958A2 (en) * 2003-03-31 2004-10-21 TEVA Gyógyszergyár Részvénytársaság Crystallization and purification of macrolides
US20050118344A1 (en) 2003-12-01 2005-06-02 Pacetti Stephen D. Temperature controlled crimping
CA2533548C (en) 2003-07-24 2010-02-16 Teva Gyogyszergyar Reszvenytarsasag Method of purifying macrolides
CN1882338A (zh) 2003-09-18 2006-12-20 马库赛特公司 经巩膜递送
US9114198B2 (en) * 2003-11-19 2015-08-25 Advanced Cardiovascular Systems, Inc. Biologically beneficial coatings for implantable devices containing fluorinated polymers and methods for fabricating the same
BRPI0417437A (pt) * 2003-12-10 2007-03-06 Acrux Dds Pty Ltd dispositivo para inibição da absorção, dispositivo para remoção de agente fisiologicamente ativo e dispositivo para redução do efeito de overdose
US8551512B2 (en) * 2004-03-22 2013-10-08 Advanced Cardiovascular Systems, Inc. Polyethylene glycol/poly(butylene terephthalate) copolymer coated devices including EVEROLIMUS
US20060094744A1 (en) * 2004-09-29 2006-05-04 Maryanoff Cynthia A Pharmaceutical dosage forms of stable amorphous rapamycin like compounds
WO2006086744A1 (en) 2005-02-09 2006-08-17 Macusight, Inc. Formulations for ocular treatment
US20070128731A1 (en) * 2005-12-07 2007-06-07 Wyeth Methods for preparing crystalline rapamycin and for measuring crystallinity of rapamycin compounds using differential scanning calorimetry
US7700614B2 (en) * 2005-12-14 2010-04-20 Abbott Laboratories One pot synthesis of tetrazole derivatives of rapamycin
AR058561A1 (es) * 2005-12-20 2008-02-13 Wyeth Corp Control de la estabilidad de la forma de dosificacion de cci -779 a traves del control de impurezas de sustancias de farmaco
JP5528708B2 (ja) * 2006-02-09 2014-06-25 参天製薬株式会社 安定な製剤ならびにそれらを調製および使用する方法
ES2563288T3 (es) 2006-03-23 2016-03-14 Santen Pharmaceutical Co., Ltd Rapamicina en dosis bajas para el tratamiento de enfermedades relacionadas con la permeabilidad vascular
JP2013527223A (ja) 2010-06-02 2013-06-27 フレゼニウス・カビ・オンコロジー・リミテッド ラパマイシンエステルの安定な医薬組成物
JP2013529224A (ja) * 2010-06-07 2013-07-18 テリック，インコーポレイテッド 結晶性エザチオスタット塩酸塩非溶媒和物
US9321782B2 (en) * 2010-08-04 2016-04-26 Meril Life Sciences Pvt. Ltd. Process for preparation of novel 42-O-(heteroalkoxyalkyl) rapamicin compounds with anti-proliferative properties
US9079921B2 (en) 2010-11-19 2015-07-14 Biocon Limited Processes for preparation of Everolimus and intermediates thereof
JP2014516075A (ja) 2011-06-06 2014-07-07 シェブロン フィリップス ケミカル カンパニー エルピー 癌治療のためのメタロセン化合物の使用
WO2013022201A1 (en) * 2011-08-11 2013-02-14 Dong-A Pharm. Co., Ltd. Process of preparing a stabilized and solubilized formulation of sirolimus derivatives
US9610385B2 (en) 2013-03-07 2017-04-04 Abbott Cardiovascular Systems Inc. Method of fabricating an implantable medical device comprising a rapamycin derivative
IN2013MU02532A (de) 2013-07-31 2015-06-26 Sahajanand Medical Technologies Pvt Ltd
CN104721158B (zh) * 2013-12-24 2018-01-30 正大天晴药业集团股份有限公司 一种稳定的依维莫司片剂
CN104892632B (zh) * 2015-06-03 2017-12-26 道中道（菏泽）制药有限公司 一种晶体形式的依维莫司及其制备方法
EP3329916A4 (de) 2015-07-28 2019-03-20 Nippon Kayaku Kabushiki Kaisha Pharmazeutische zusammensetzung mit rapamycin oder derivat davon und herstellungsverfahren dafür
WO2017038612A1 (ja) * 2015-08-28 2017-03-09 日本化薬株式会社 ラパマイシン又はその誘導体を含有する医薬組成物
WO2017047618A1 (ja) * 2015-09-18 2017-03-23 日本化薬株式会社 ラパマイシン又はその誘導体を含有する医薬組成物
WO2017129772A1 (en) 2016-01-29 2017-08-03 Xellia Phamaceuticals Aps Stable pharmaceutical compositions of temsirolimus
JP6855470B2 (ja) 2016-05-27 2021-04-07 日本化薬株式会社 ラパマイシン又はその誘導体を含有する医薬組成物
KR102051806B1 (ko) * 2018-01-12 2019-12-04 주식회사 종근당 에베로리무스를 포함하는 안정화된 약제학적 제제
CN119431400A (zh) * 2020-03-27 2025-02-14 波士顿科学国际有限公司 用于使药物结晶的方法
JP2023028473A (ja) * 2021-08-19 2023-03-03 日本マイクロバイオファーマ株式会社 エベロリムスの製造方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA737247B (en) * 1972-09-29 1975-04-30 Ayerst Mckenna & Harrison Rapamycin and process of preparation
US3996355A (en) 1975-01-02 1976-12-07 American Home Products Corporation Permanent suspension pharmaceutical dosage form
US4049128A (en) 1976-11-18 1977-09-20 Westinghouse Air Brake Company Control system for automatic railway car coupler
AU543727B2 (en) * 1980-06-02 1985-05-02 Ayerst Mckenna & Harrison Inc. Injectable composition of rapamycin
GB8803836D0 (en) 1988-02-18 1988-03-16 Glaxo Group Ltd Compositions
JPH01249651A (ja) † 1988-02-18 1989-10-04 E I Du Pont De Nemours & Co セラミツク／蒸留可能な結合剤組成物
KR0159766B1 (ko) * 1989-10-16 1998-12-01 후지사와 토모키치로 양모제 조성물
JPH04230389A (ja) * 1990-07-16 1992-08-19 American Home Prod Corp ラパマイシン誘導体
JP3108192B2 (ja) * 1991-05-07 2000-11-13 アメリカン・ホーム・プロダクツ・コーポレイション 免疫抑制剤、抗炎症剤または抗真菌剤用ラパマイシンの還元生成物
GB9221220D0 (en) * 1992-10-09 1992-11-25 Sandoz Ag Organic componds
US5302584A (en) * 1992-10-13 1994-04-12 American Home Products Corporation Carbamates of rapamycin
EP0593227B1 (de) 1992-10-13 2006-03-22 Wyeth Carbamate von Rapamycin
RU2181054C2 (ru) * 1994-11-02 2002-04-10 Новартис Аг Микроэмульсионный предконцентрат
IL122212A (en) * 1995-06-09 2001-08-26 Novartis Ag Rapamycin derivatives, pharmaceutical compositions comprising them and their preparation
FR2736550B1 (fr) * 1995-07-14 1998-07-24 Sandoz Sa Composition pharmaceutique sous la forme d'une dispersion solide comprenant un macrolide et un vehicule
ATE340586T1 (de) * 1996-07-30 2006-10-15 Novartis Pharma Gmbh Pharmazeutische zusammensetzungen zur behandlung der transplantatabstossung sowie der autoimmun- oder entzündlichen zustände
US6362264B1 (en) * 1996-12-20 2002-03-26 Ck Witco Corporation Stabilizer for food contact and medical grade PVC
WO1998033482A1 (en) 1997-02-04 1998-08-06 Abbott Laboratories Pain reducing parenteral liposome formulation

Also Published As

Publication number Publication date
NO20012424D0 (no) 2001-05-16
CN1876657A (zh) 2006-12-13
JP2006111637A (ja) 2006-04-27
US6605613B2 (en) 2003-08-12
TW200540179A (en) 2005-12-16
MY120594A (en) 2005-11-30
CY1106870T1 (el) 2012-09-26
DK1137439T3 (da) 2007-09-10
PL196627B1 (pl) 2008-01-31
SK286688B6 (sk) 2009-03-05
PE20001333A1 (es) 2000-12-12
HU230174B1 (hu) 2015-09-28
PL208854B1 (pl) 2011-06-30
AR048073A2 (es) 2006-03-29
TWI248938B (en) 2006-02-11
NO332698B1 (no) 2012-12-10
US20080161334A1 (en) 2008-07-03
US20050107418A1 (en) 2005-05-19
MY127579A (en) 2006-12-29
CZ303006B6 (cs) 2012-02-22
SI1137439T1 (sl) 2008-06-30
BR9915986A (pt) 2001-09-04
EP2279751A3 (de) 2011-02-16
DE69936352T2 (de) 2008-02-14
SI1137439T2 (sl) 2012-05-31
CZ302210B6 (cs) 2010-12-22
US7741338B2 (en) 2010-06-22
ES2288033T5 (es) 2012-04-10
AU759219B2 (en) 2003-04-10
ES2288033T3 (es) 2007-12-16
TR200101416T2 (tr) 2002-01-21
US20020032213A1 (en) 2002-03-14
GB9826882D0 (en) 1999-01-27
US20030191148A1 (en) 2003-10-09
IT1319701B1 (it) 2003-10-27
BE1012869A3 (fr) 2001-04-03
JP5043308B2 (ja) 2012-10-10
CO4980847A1 (es) 2000-11-27
HUP0104489A2 (hu) 2002-03-28
DE69936352D1 (de) 2007-08-02
EP2279751A2 (de) 2011-02-02
EP1743657A3 (de) 2007-03-28
HU228939B1 (en) 2013-07-29
EP1137439B2 (de) 2011-11-23
EP2269651A2 (de) 2011-01-05
AR054444A2 (es) 2007-06-27
FR2786771A1 (fr) 2000-06-09
ATE365051T1 (de) 2007-07-15
SK287325B6 (sk) 2010-07-07
CA2732620A1 (en) 2000-06-15
US7572804B2 (en) 2009-08-11
EP2269651A3 (de) 2011-03-09
CN1374872A (zh) 2002-10-16
US6852729B2 (en) 2005-02-08
EP1137439A2 (de) 2001-10-04
RU2243769C2 (ru) 2005-01-10
FR2786771B1 (fr) 2002-12-27
JP5165199B2 (ja) 2013-03-21
CN1876657B (zh) 2013-01-09
JP3805625B2 (ja) 2006-08-02
NO334612B1 (no) 2014-04-22
SK7662001A3 (en) 2001-12-03
KR100695834B1 (ko) 2007-03-19
US20090270441A1 (en) 2009-10-29
GB9904934D0 (en) 1999-04-28
AR026102A1 (es) 2003-01-29
IL143092A0 (en) 2002-04-21
ITMI992520A1 (it) 2001-06-02
EP1743657A2 (de) 2007-01-17
WO2000033878A3 (en) 2000-11-02
DE69936352T3 (de) 2012-05-03
PL348333A1 (en) 2002-05-20
ZA200104360B (en) 2002-01-16
SG151072A1 (en) 2009-06-29
HUP0104489A3 (en) 2004-05-28
CA2732620C (en) 2013-08-06
US7297703B2 (en) 2007-11-20
DK1137439T4 (da) 2012-03-19
TWI270550B (en) 2007-01-11
HK1038889B (en) 2008-01-25
PT1137439E (pt) 2007-09-25
KR20010101128A (ko) 2001-11-14
TR200201428T2 (tr) 2002-12-23
CZ20012001A3 (cs) 2001-09-12
NO20121113L (no) 2001-05-16
JP2005200429A (ja) 2005-07-28
WO2000033878A2 (en) 2000-06-15
HK1038889A1 (en) 2002-04-04
AU1657300A (en) 2000-06-26
NZ511936A (en) 2003-10-31
CN1261163C (zh) 2006-06-28
ITMI992520A0 (it) 1999-12-02
CA2651609A1 (en) 2000-06-15
EP1137439B1 (de) 2007-06-20
NZ527781A (en) 2004-11-26
CA2351580A1 (en) 2000-06-15
NO20012424L (no) 2001-05-16
JP2002531527A (ja) 2002-09-24
KR20060096477A (ko) 2006-09-11
CA2351580C (en) 2012-03-20

Similar Documents

Publication Publication Date Title
ID29250A (id) Stabilisasi makrolida
DE69829040D1 (de) Elektroplattierungschemie
DE59914158D1 (de) Metallocenmonohalogenide
ATE341990T1 (de) Sigmidoskop
DE59911453D1 (de) Aktivkohlefilter
DE59912371D1 (de) Gleitschalungsfertiger
DE69835302D1 (de) Tintenbehälternachfüllsystem
DE59902874D1 (de) Buchsenkontakt
DE59901560D1 (de) Retrograder tibianagel
DE69828209D1 (de) Flanschreformierung
DE59907306D1 (de) Fadenchangierung
DE59906931D1 (de) Exzenterzahnradgetriebe
DE59911683D1 (de) Fahrzeugschliessanlage
DE69902762D1 (de) Riser-spannanordnung
DE69811890D1 (de) Einzellenkalorimeter
ATE262513T1 (de) Benzoylpyridazine
DE59903966D1 (de) Exzenterzahnradgetriebe
DE59913393D1 (de) Fadenchangierung
DE69827358D1 (de) Weglenkungsverfahren
DE59908769D1 (de) N-arylsulfonyl-aminosäure-omega-amide
DE69820261D1 (de) Steuerventilanordnnung
DE59903106D1 (de) Tripode-gleichlaufdrehgelenk
DE59908057D1 (de) Underdruckhandhabungseinrichung
DE69809804D1 (de) Notlaufgeländereifen
DE59901046D1 (de) Methylcyclotetradec-5-en-1-one